SV2A
protein-codingsynaptic vesicle glycoprotein 2A, the group of Solute carrier family 22
Gene summary
The protein encoded by this gene is one of three related synaptic vesicle proteins. The encoded protein may interact with synaptotagmin to enhance low frequency neurotransmission in quiescent neurons. [provided by RefSeq, Jun 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~14.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: SD
Disease ID:MONDO:0958330
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0958330
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0005027
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SV2A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014849.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 15 | 5 | 24 | ||
| missense | 78 | 2 | 80 | |||
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 2 | 84 | 17 | 5 | 109 |
Highest pathogenic variant AF is 0.0000061566498
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055664.3 | 12 | MANE Select | |
| Ensembl | ENSP00000358142.3 | 12 | MANE Select | |
| RefSeq | NP_001265648.1 | 3 | Standard | |
| RefSeq | NP_001315603.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- ECM-receptor interaction - Homo sapiens (human)
- Disease
- Toxicity of botulinum toxin type A (BoNT/A)
- Toxicity of botulinum toxin type D (BoNT/D)
- Toxicity of botulinum toxin type F (BoNT/F)
Biological Process
- cellular calcium ion homeostasis
- regulation of gamma-aminobutyric acid secretion
- synaptic vesicle priming
- transmembrane transport
Molecular Function
- protein kinase binding
- transmembrane transporter activity
Cellular Component
- endoplasmic reticulum
- plasma membrane
- cell-cell junction
- synaptic vesicle
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369146
- Coding exons
- 12
- Length
- 14565
- Individuals with no LoFs
- 125733
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 15
- Defined
- 125748
- p
- 0.0000596
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.12 | 328 | 455 | 0.721 | 0.0000285 | 4853 |
| Missense (PolyPhen) | 84 | 198.11 | 0.42401 | 2202 | ||
| Synonymous | 0.200 | 185 | 189 | 0.981 | 0.0000123 | 1501 |
| Loss of Function | 4.36 | 9 | 38.0 | 0.237 | 0.00000246 | 366 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000070 | 0.000070 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.345
Intolerance Scores
- LoFtool
- 0.393
- RVIS EVS
- -1.24
- RVIS percentile EVS
- 5.41
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.126
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |